查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球合成胜肽疫苗市場考察及預測（至2031年）
市場調查報告書
商品編碼
1681576

全球合成胜肽疫苗市場考察及預測（至2031年）

Global Synthetic Peptide Vaccine Market Insights, Forecast to 2031
出版日期: | 出版商: QYResearch | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球合成胜肽疫苗市場規模預計將從 2024 年的 1.1452 億美元增至 2031 年的 1.893 億美元，2025-2031 年預測期內的複合年成長率為 7.36%。

目前，人用合成胜肽疫苗均處於研發和測試階段，市面上銷售的只有獸用疫苗，主要是豬口蹄疫疫苗。

中國合成胜肽疫苗市場規模預計將從 2024 年的 9,824 萬美元增至 2031 年的 1.6182 億美元，預測期內（2025-2031 年）的複合年成長率為 7.29%。

全球合成胜肽疫苗主要生產商有United Biomedical、CAHIC、新疆特康、ISA Pharmaceuticals、Lytix Biopharma、Merck、OncoTherapy Science、Circio、Stemline Therapeutics、Treos Bio等。

本報告對全球合成胜肽疫苗市場進行了深入分析，提供了各地區市場規模及預測、主要企業排名、市場佔有率等資訊。

目錄

第1章 調查範圍

  • 合成胜肽疫苗產品介紹
  • 按類型分類的市場
    • 全球合成胜肽疫苗市場規模成長率（按類型分類）（2020、2024、2031）
    • O型口蹄疫
    • 口蹄疫O型+A型
    • 其他
  • 市場：按應用
    • 全球合成胜肽疫苗市場規模成長率（按應用分類）（2020 年、2024 年、2031 年）
    • 政府採購
    • 直接銷售
  • 先決條件和限制
  • 研究目標
  • 考慮的年數

第 2 章執行摘要

  • 全球合成胜肽疫苗收益估計及預測（2020-2031）
  • 全球合成胜肽疫苗收益（按地區）
    • 全球合成胜肽疫苗收益按地區分類（2020 年、2024 年、2031 年）
    • 全球合成胜肽疫苗收益（按地區）（2020-2025）
    • 全球合成胜肽疫苗收益（按地區） (2026-2031)
    • 全球合成胜肽疫苗各地區收益市場佔有率（2020-2031）
  • 全球合成胜肽疫苗銷售量估計及預測（2020-2031）
  • 全球合成胜肽疫苗銷售區域分佈
    • 全球合成胜肽疫苗銷售量（按地區分類）(2020, 2024, 2031)
    • 全球合成胜肽疫苗銷售量（按地區）（2020-2025）
    • 全球合成胜肽疫苗銷售量（按地區） (2026-2031)
    • 全球合成胜肽疫苗各地區銷售市場佔有率（2020-2031）
  • 美國/加拿大
  • 歐洲
  • 中國
  • 亞洲（不包括中國）
  • 中東、非洲和拉丁美洲

第3章 廠商間的競爭

  • 全球合成胜肽疫苗製造商銷售額
    • 全球合成胜肽疫苗製造商銷售額（2020-2025）
    • 全球合成胜肽疫苗製造商銷售市場佔有率（2020-2025 年）
  • 全球合成胜肽疫苗製造商收益：
    • 全球合成胜肽疫苗收益按製造商分類（2020-2025 年）
    • 全球合成胜肽疫苗製造商收益市場佔有率佔有率（2020-2025）
  • 全球合成胜肽疫苗產業主要企業排名（2024年）
  • 全球合成胜肽疫苗製造商銷售價格（2020-2025年）
  • 全球主要合成胜肽疫苗生產公司、製造地及總部分佈
  • 全球主要合成胜肽疫苗生產企業及產品
  • 全球主要合成胜肽疫苗生產企業及成立時間
  • 併購、擴張計劃

第4章 市場規模（按類型）

  • 全球合成胜肽疫苗銷售（按類型）
    • 全球合成胜肽疫苗銷售表現（按類型）（2020-2025）
    • 全球合成胜肽疫苗銷售預測（按類型）（2026-2031）
    • 全球合成胜肽疫苗銷售市場佔有率（按類型分類）（2020-2031 年）
  • 全球合成胜肽疫苗收益（按類型）
    • 全球合成胜肽疫苗收益表現（按類型）（2020-2025）
    • 全球合成胜肽疫苗收益預測（按類型）（2026-2031）
    • 全球合成胜肽疫苗收益市場佔有率（按類型）（2020-2031）
  • 全球合成胜肽疫苗價格（按類型）
    • 全球合成胜肽疫苗價格（按類型分類）（2020-2025）
    • 全球合成胜肽疫苗價格預測（按類型）（2026-2031）

第 5 章 按應用分類的市場規模

  • 全球合成胜肽疫苗銷售（按應用）
    • 全球合成胜肽疫苗銷售表現（按應用） (2020-2025)
    • 全球合成胜肽疫苗銷售預測（按應用） (2026-2031)
    • 全球合成胜肽疫苗按應用分類的銷售市場佔有率（2020-2031）
  • 全球合成胜肽疫苗收益（按應用）
    • 全球合成胜肽疫苗按應用分類的收益表現（2020-2025 年）
    • 全球合成胜肽疫苗收益預測（按應用分類）（2026-2031）
    • 全球合成胜肽疫苗按應用分類的收益市場佔有率（2020-2031）
  • 全球合成胜肽疫苗價格（按應用）
    • 全球合成胜肽疫苗價格（按應用分類）（2020-2025）
    • 全球合成胜肽疫苗價格預測（按應用） (2026-2031)

第6章美國和加拿大

  • 美國和加拿大合成胜肽疫苗市場規模（按類型）
    • 美國和加拿大合成胜肽疫苗銷量（按類型）（2020-2031）
    • 美國和加拿大合成胜肽疫苗收益（按類型）（2020-2031）
  • 美國和加拿大合成胜肽疫苗市場規模（按應用）
    • 美國和加拿大合成胜肽疫苗銷量（按應用分類）（2020-2031）
    • 美國和加拿大合成胜肽疫苗收益（按應用分類）（2020-2031）
  • 美國和加拿大合成胜肽疫苗市場規模（按國家）
    • 美國和加拿大合成胜肽疫苗收益（按國家/地區分類）（2020-2031 年）
    • 美國和加拿大合成胜肽疫苗銷售（按國家/地區分類）（2020-2031 年）
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲

  • 歐洲合成胜肽疫苗市場規模（按類型）
    • 歐洲合成胜肽疫苗銷售（按類型）（2020-2031）
    • 歐洲合成胜肽疫苗收益（按類型）（2020-2031）
  • 歐洲合成胜肽疫苗市場規模（依應用）
    • 歐洲合成胜肽疫苗銷售量（依應用分類）（2020-2031）
    • 歐洲合成胜肽疫苗收益（按應用分類）（2020-2031）
  • 歐洲合成胜肽疫苗市場規模（依國家）
    • 歐洲合成胜肽疫苗收益（按國家/地區分類）（2020-2031 年）
    • 歐洲合成胜肽疫苗銷售量（依國家/地區） (2020-2031)
    • 德國
    • 法國
    • 英國
    • 義大利
    • 俄羅斯

第8章 中國

  • 中國合成胜肽疫苗市場規模（按類型）
    • 中國合成胜肽疫苗銷售（按類型）（2020-2031）
    • 中國合成胜肽疫苗收益（按類型）（2020-2031）
  • 中國合成胜肽疫苗市場規模（依應用）
    • 中國合成胜肽疫苗銷售（按應用分類）（2020-2031）
    • 中國合成胜肽疫苗收益（按應用分類）（2020-2031）

第9章 亞洲（不包括中國）

  • 亞洲合成胜肽疫苗市場規模（按類型）
    • 亞洲合成胜肽疫苗銷售（按類型）（2020-2031）
    • 亞洲合成胜肽疫苗收益（按類型）（2020-2031）
  • 亞洲合成胜肽疫苗市場規模（依應用）
    • 亞洲合成胜肽疫苗銷售（按應用分類）（2020-2031）
    • 亞洲合成胜肽疫苗收益（按應用分類）（2020-2031）
  • 亞洲合成胜肽疫苗市場規模（按地區）
    • 亞洲合成胜肽疫苗收益（按地區）（2020-2031）
    • 亞洲合成胜肽疫苗銷售額（按地區） (2020-2031)
    • 日本
    • 韓國
    • 台灣
    • 東南亞
    • 印度

第 10 章：中東、非洲和拉丁美洲

  • 中東、非洲和拉丁美洲合成胜肽疫苗市場規模（按類型）
    • 中東、非洲和拉丁美洲合成胜肽疫苗銷量（按類型）（2020-2031 年）
    • 中東、非洲和拉丁美洲合成胜肽疫苗收益（按類型）（2020-2031 年）
  • 中東、非洲和拉丁美洲合成胜肽疫苗市場規模（按應用）
    • 中東、非洲和拉丁美洲合成胜肽疫苗銷售情況（按應用分類）（2020-2031 年）
    • 中東、非洲和拉丁美洲合成胜肽疫苗收益（按應用分類）（2020-2031 年）
  • 中東、非洲和拉丁美洲各國合成胜肽疫苗市場規模
    • 中東、非洲和拉丁美洲合成胜肽疫苗收益（按國家/地區分類）（2020-2031 年）
    • 中東、非洲和拉丁美洲合成胜肽疫苗銷售情況（按國家分類）（2020-2031 年）
    • 拉丁美洲
    • 中東
    • 非洲

第11章 公司簡介

  • United Biomedical
  • CAHIC
  • Xinjiang Tecon
  • ISA Pharmaceuticals
  • Lytix Biopharma
  • Merck
  • OncoTherapy Science
  • Circio
  • Stemline Therapeutics
  • Treos Bio

第12章 產業鍊及銷售管道分析

  • 合成胜肽疫苗產業鏈分析
  • 合成胜肽疫苗的主要原料
    • 主要成分
    • 主要原料供應商
  • 合成胜肽疫苗的生產方法及工藝
  • 合成胜肽疫苗的銷售與行銷

第13章合成胜肽疫苗市場動態

  • 合成胜肽疫苗產業趨勢
  • 合成胜肽疫苗市場促進因素
  • 合成胜肽疫苗市場的問題
  • 限制合成胜肽疫苗市場的因素

第 14 章全球合成胜肽疫苗研究的主要發現

第15章 附錄

The global Synthetic Peptide Vaccine market is projected to grow from US$ 114.52 million in 2024 to US$ 189.30 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.36% during the forecast period 2025-2031.

Currently, synthetic peptide vaccines for human use are all in the research and development/trial stage, and the only commercially available vaccines are for veterinary use, mainly swine foot-and-mouth disease vaccines.

The China market for Synthetic Peptide Vaccine is estimated to increase from $ 98.24 million in 2024 to reach $ 161.82 million by 2031, at a CAGR of 7.29% during the forecast period of 2025 through 2031.

The global key manufacturers of Synthetic Peptide Vaccine include United Biomedical, CAHIC, Xinjiang Tecon, ISA Pharmaceuticals, Lytix Biopharma, Merck, OncoTherapy Science, Circio, Stemline Therapeutics, and Treos Bio, etc.

Report Includes

This report presents an overview of global market for Synthetic Peptide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Synthetic Peptide Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Synthetic Peptide Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Synthetic Peptide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Synthetic Peptide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Synthetic Peptide Vaccine sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including ISA Pharmaceuticals, Lytix Biopharma, CAHIC, United Biomedical, Merck, OncoTherapy Science, Circio, Stemline Therapeutics, and Treos Bio, etc.

Market Segmentation

By Company

  • United Biomedical
  • CAHIC
  • Xinjiang Tecon
  • ISA Pharmaceuticals
  • Lytix Biopharma
  • Merck
  • OncoTherapy Science
  • Circio
  • Stemline Therapeutics
  • Treos Bio

Segment by Type

  • FMD Type O
  • FMD Type O+A
  • Others

Segment by Application

  • Government Procurement
  • Direct Sales

Segment by Region

US & Canada

  • U.S.
  • Canada
  • Mexico

China

Asia (excluding China)

  • Japan
  • South Korea
  • China Taiwan
  • Southeast Asia
  • India
  • Australia

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Russia

Middle East, Africa, Latin America

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Synthetic Peptide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Synthetic Peptide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Peptide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

  • 1.1 Synthetic Peptide Vaccine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
    • 1.2.2 FMD Type O
    • 1.2.3 FMD Type O+A
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
    • 1.3.2 Government Procurement
    • 1.3.3 Direct Sales
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Synthetic Peptide Vaccine Revenue Estimates and Forecasts 2020-2031
  • 2.2 Global Synthetic Peptide Vaccine Revenue by Region
    • 2.2.1 Global Synthetic Peptide Vaccine Revenue by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Global Synthetic Peptide Vaccine Revenue by Region (2020-2025)
    • 2.2.3 Global Synthetic Peptide Vaccine Revenue by Region (2026-2031)
    • 2.2.4 Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2031)
  • 2.3 Global Synthetic Peptide Vaccine Sales Estimates and Forecasts 2020-2031
  • 2.4 Global Synthetic Peptide Vaccine Sales by Region
    • 2.4.1 Global Synthetic Peptide Vaccine Sales by Region: 2020 VS 2024 VS 2031
    • 2.4.2 Global Synthetic Peptide Vaccine Sales by Region (2020-2025)
    • 2.4.3 Global Synthetic Peptide Vaccine Sales by Region (2026-2031)
    • 2.4.4 Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2031)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Synthetic Peptide Vaccine Sales by Manufacturers
    • 3.1.1 Global Synthetic Peptide Vaccine Sales by Manufacturers (2020-2025)
    • 3.1.2 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2020-2025)
  • 3.2 Global Synthetic Peptide Vaccine Revenue by Manufacturers
    • 3.2.1 Global Synthetic Peptide Vaccine Revenue by Manufacturers (2020-2025)
    • 3.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025)
  • 3.3 Global Key Players of Synthetic Peptide Vaccine, Industry Ranking in 2024
  • 3.4 Global Synthetic Peptide Vaccine Sales Price by Manufacturers (2020-2025)
  • 3.5 Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Base Distribution and Headquarters
  • 3.6 Global Key Manufacturers of Synthetic Peptide Vaccine, Product Offered
  • 3.7 Global Key Manufacturers of Synthetic Peptide Vaccine, Founded Date
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Synthetic Peptide Vaccine Sales by Type
    • 4.1.1 Global Synthetic Peptide Vaccine Historical Sales by Type (2020-2025)
    • 4.1.2 Global Synthetic Peptide Vaccine Forecasted Sales by Type (2026-2031)
    • 4.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Type (2020-2031)
  • 4.2 Global Synthetic Peptide Vaccine Revenue by Type
    • 4.2.1 Global Synthetic Peptide Vaccine Historical Revenue by Type (2020-2025)
    • 4.2.2 Global Synthetic Peptide Vaccine Forecasted Revenue by Type (2026-2031)
    • 4.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2020-2031)
  • 4.3 Global Synthetic Peptide Vaccine Price by Type
    • 4.3.1 Global Synthetic Peptide Vaccine Price by Type (2020-2025)
    • 4.3.2 Global Synthetic Peptide Vaccine Price Forecast by Type (2026-2031)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Synthetic Peptide Vaccine Sales by Application
    • 5.1.1 Global Synthetic Peptide Vaccine Historical Sales by Application (2020-2025)
    • 5.1.2 Global Synthetic Peptide Vaccine Forecasted Sales by Application (2026-2031)
    • 5.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Application (2020-2031)
  • 5.2 Global Synthetic Peptide Vaccine Revenue by Application
    • 5.2.1 Global Synthetic Peptide Vaccine Historical Revenue by Application (2020-2025)
    • 5.2.2 Global Synthetic Peptide Vaccine Forecasted Revenue by Application (2026-2031)
    • 5.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2020-2031)
  • 5.3 Global Synthetic Peptide Vaccine Price by Application
    • 5.3.1 Global Synthetic Peptide Vaccine Price by Application (2020-2025)
    • 5.3.2 Global Synthetic Peptide Vaccine Price Forecast by Application (2026-2031)

6 US & CANADA

  • 6.1 US & Canada Synthetic Peptide Vaccine Market Size by Type
    • 6.1.1 US & Canada Synthetic Peptide Vaccine Sales by Type (2020-2031)
    • 6.1.2 US & Canada Synthetic Peptide Vaccine Revenue by Type (2020-2031)
  • 6.2 US & Canada Synthetic Peptide Vaccine Market Size by Application
    • 6.2.1 US & Canada Synthetic Peptide Vaccine Sales by Application (2020-2031)
    • 6.2.2 US & Canada Synthetic Peptide Vaccine Revenue by Application (2020-2031)
  • 6.3 US & Canada Synthetic Peptide Vaccine Market Size by Country
    • 6.3.1 US & Canada Synthetic Peptide Vaccine Revenue by Country (2020-2031)
    • 6.3.2 US & Canada Synthetic Peptide Vaccine Sales by Country (2020-2031)
    • 6.3.3 US
    • 6.3.4 Canada
    • 6.3.5 Mexico

7 EUROPE

  • 7.1 Europe Synthetic Peptide Vaccine Market Size by Type
    • 7.1.1 Europe Synthetic Peptide Vaccine Sales by Type (2020-2031)
    • 7.1.2 Europe Synthetic Peptide Vaccine Revenue by Type (2020-2031)
  • 7.2 Europe Synthetic Peptide Vaccine Market Size by Application
    • 7.2.1 Europe Synthetic Peptide Vaccine Sales by Application (2020-2031)
    • 7.2.2 Europe Synthetic Peptide Vaccine Revenue by Application (2020-2031)
  • 7.3 Europe Synthetic Peptide Vaccine Market Size by Country
    • 7.3.1 Europe Synthetic Peptide Vaccine Revenue by Country (2020-2031)
    • 7.3.2 Europe Synthetic Peptide Vaccine Sales by Country (2020-2031)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 CHINA

  • 8.1 China Synthetic Peptide Vaccine Market Size by Type
    • 8.1.1 China Synthetic Peptide Vaccine Sales by Type (2020-2031)
    • 8.1.2 China Synthetic Peptide Vaccine Revenue by Type (2020-2031)
  • 8.2 China Synthetic Peptide Vaccine Market Size by Application
    • 8.2.1 China Synthetic Peptide Vaccine Sales by Application (2020-2031)
    • 8.2.2 China Synthetic Peptide Vaccine Revenue by Application (2020-2031)

9 ASIA (EXCLUDING CHINA)

  • 9.1 Asia Synthetic Peptide Vaccine Market Size by Type
    • 9.1.1 Asia Synthetic Peptide Vaccine Sales by Type (2020-2031)
    • 9.1.2 Asia Synthetic Peptide Vaccine Revenue by Type (2020-2031)
  • 9.2 Asia Synthetic Peptide Vaccine Market Size by Application
    • 9.2.1 Asia Synthetic Peptide Vaccine Sales by Application (2020-2031)
    • 9.2.2 Asia Synthetic Peptide Vaccine Revenue by Application (2020-2031)
  • 9.3 Asia Synthetic Peptide Vaccine Market Size by Region
    • 9.3.1 Asia Synthetic Peptide Vaccine Revenue by Region (2020-2031)
    • 9.3.2 Asia Synthetic Peptide Vaccine Sales by Region (2020-2031)
    • 9.3.3 Japan
    • 9.3.4 South Korea
    • 9.3.5 China Taiwan
    • 9.3.6 Southeast Asia
    • 9.3.7 India

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

  • 10.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2020-2031)
    • 10.1.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2020-2031)
  • 10.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2020-2031)
    • 10.2.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2020-2031)
  • 10.3 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2020-2031)
    • 10.3.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2020-2031)
    • 10.3.3 Latin America
    • 10.3.4 Middle East
    • 10.3.5 Africa

11 CORPORATE PROFILE

  • 11.1 United Biomedical
    • 11.1.1 United Biomedical Company Information
    • 11.1.2 United Biomedical Overview
    • 11.1.3 United Biomedical Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.1.4 United Biomedical Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 United Biomedical Recent Developments
  • 11.2 CAHIC
    • 11.2.1 CAHIC Company Information
    • 11.2.2 CAHIC Overview
    • 11.2.3 CAHIC Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.2.4 CAHIC Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3 Xinjiang Tecon
    • 11.3.1 Xinjiang Tecon Company Information
    • 11.3.2 Xinjiang Tecon Overview
    • 11.3.3 Xinjiang Tecon Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.3.4 Xinjiang Tecon Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4 ISA Pharmaceuticals
    • 11.4.1 ISA Pharmaceuticals Company Information
    • 11.4.2 ISA Pharmaceuticals Overview
    • 11.4.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5 Lytix Biopharma
    • 11.5.1 Lytix Biopharma Company Information
    • 11.5.2 Lytix Biopharma Overview
    • 11.5.3 Lytix Biopharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6 Merck
    • 11.6.1 Merck Company Information
    • 11.6.2 Merck Overview
    • 11.6.3 Merck Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7 OncoTherapy Science
    • 11.7.1 OncoTherapy Science Company Information
    • 11.7.2 OncoTherapy Science Overview
    • 11.7.3 OncoTherapy Science Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8 Circio
    • 11.8.1 Circio Company Information
    • 11.8.2 Circio Overview
    • 11.8.3 Circio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.4 Circio Recent Developments
  • 11.9 Stemline Therapeutics
    • 11.9.1 Stemline Therapeutics Company Information
    • 11.9.2 Stemline Therapeutics Overview
    • 11.9.3 Stemline Therapeutics Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10 Treos Bio
    • 11.10.1 Treos Bio Company Information
    • 11.10.2 Treos Bio Overview
    • 11.10.3 Treos Bio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Synthetic Peptide Vaccine Industry Chain Analysis
  • 12.2 Synthetic Peptide Vaccine Key Raw Material
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Synthetic Peptide Vaccine Production Mode & Process
  • 12.4 Synthetic Peptide Vaccine Sales and Marketing

13 SYNTHETIC PEPTIDE VACCINE MARKET DYNAMICS

    • 13.1.1 Synthetic Peptide Vaccine Industry Trends
    • 13.1.2 Synthetic Peptide Vaccine Market Drivers
    • 13.1.3 Synthetic Peptide Vaccine Market Challenges
    • 13.1.4 Synthetic Peptide Vaccine Market Restraints

14 KEY FINDINGS IN THE GLOBAL SYNTHETIC PEPTIDE VACCINE STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer 127

List of Tables

  • Table 1. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
  • Table 2. Major Manufacturers of FMD Type O
  • Table 3. Major Manufacturers of FMD Type O+A
  • Table 4. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
  • Table 5. Global Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 6. Global Synthetic Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million)
  • Table 7. Global Synthetic Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million)
  • Table 8. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2025)
  • Table 9. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2026-2031)
  • Table 10. Global Synthetic Peptide Vaccine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M ml)
  • Table 11. Global Synthetic Peptide Vaccine Sales by Region (2020-2025) & (M ml)
  • Table 12. Global Synthetic Peptide Vaccine Sales by Region (2026-2031) & (M ml)
  • Table 13. Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2025)
  • Table 14. Global Synthetic Peptide Vaccine Sales Market Share by Region (2026-2031)
  • Table 15. Global Synthetic Peptide Vaccine Sales by Manufacturers (2020-2025) & (M ml)
  • Table 16. Global Synthetic Peptide Vaccine Sales Share by Manufacturers (2020-2025)
  • Table 17. Global Synthetic Peptide Vaccine Revenue by Manufacturers (2020-2025) & (US$ Million)
  • Table 18. Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025)
  • Table 19. Global Key Players of Synthetic Peptide Vaccine, Industry Ranking in 2024
  • Table 20. Synthetic Peptide Vaccine Price by Manufacturers (2020-2025) & (USD/Litre)
  • Table 21. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Base Distribution and Headquarters
  • Table 22. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Offered
  • Table 23. Global Key Manufacturers of Synthetic Peptide Vaccine, Founded Date
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
  • Table 26. Global Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml)
  • Table 27. Global Synthetic Peptide Vaccine Sales Share by Type (2020-2025)
  • Table 28. Global Synthetic Peptide Vaccine Sales Share by Type (2026-2031)
  • Table 29. Global Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million)
  • Table 30. Global Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million)
  • Table 31. Global Synthetic Peptide Vaccine Revenue Share by Type (2020-2025)
  • Table 32. Global Synthetic Peptide Vaccine Revenue Share by Type (2026-2031)
  • Table 33. Synthetic Peptide Vaccine Price by Type (2020-2025) & (USD/Litre)
  • Table 34. Global Synthetic Peptide Vaccine Price Forecast by Type (2026-2031) & (USD/Litre)
  • Table 35. Global Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
  • Table 36. Global Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml)
  • Table 37. Global Synthetic Peptide Vaccine Sales Share by Application (2020-2025)
  • Table 38. Global Synthetic Peptide Vaccine Sales Share by Application (2026-2031)
  • Table 39. Global Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million)
  • Table 40. Global Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million)
  • Table 41. Global Synthetic Peptide Vaccine Revenue Share by Application (2020-2025)
  • Table 42. Global Synthetic Peptide Vaccine Revenue Share by Application (2026-2031)
  • Table 43. Synthetic Peptide Vaccine Price by Application (2020-2025) & (USD/Litre)
  • Table 44. Global Synthetic Peptide Vaccine Price Forecast by Application (2026-2031) & (USD/Litre)
  • Table 45. US & Canada Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
  • Table 46. US & Canada Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml)
  • Table 47. US & Canada Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million)
  • Table 48. US & Canada Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million)
  • Table 49. US & Canada Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
  • Table 50. US & Canada Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml)
  • Table 51. US & Canada Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million)
  • Table 52. US & Canada Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million)
  • Table 53. US & Canada Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
  • Table 54. US & Canada Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
  • Table 55. US & Canada Synthetic Peptide Vaccine Sales by Country (2020-2025) & (M ml)
  • Table 56. US & Canada Synthetic Peptide Vaccine Sales by Country (2026-2031) & (M ml)
  • Table 57. Europe Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
  • Table 58. Europe Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml)
  • Table 59. Europe Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million)
  • Table 60. Europe Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million)
  • Table 61. Europe Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
  • Table 62. Europe Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml)
  • Table 63. Europe Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million)
  • Table 64. Europe Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million)
  • Table 65. Europe Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
  • Table 66. Europe Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
  • Table 67. Europe Synthetic Peptide Vaccine Sales by Country (2020-2025) & (M ml)
  • Table 68. Europe Synthetic Peptide Vaccine Sales by Country (2026-2031) & (M ml)
  • Table 69. China Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
  • Table 70. China Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml)
  • Table 71. China Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million)
  • Table 72. China Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million)
  • Table 73. China Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
  • Table 74. China Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml)
  • Table 75. China Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million)
  • Table 76. China Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million)
  • Table 77. Asia Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
  • Table 78. Asia Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml)
  • Table 79. Asia Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million)
  • Table 80. Asia Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million)
  • Table 81. Asia Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
  • Table 82. Asia Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml)
  • Table 83. Asia Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million)
  • Table 84. Asia Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million)
  • Table 85. Asia Synthetic Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million)
  • Table 86. Asia Synthetic Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million)
  • Table 87. Asia Synthetic Peptide Vaccine Sales by Region (2020-2025) & (M ml)
  • Table 88. Asia Synthetic Peptide Vaccine Sales by Region (2026-2031) & (M ml)
  • Table 89. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
  • Table 90. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml)
  • Table 91. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million)
  • Table 92. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million)
  • Table 93. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
  • Table 94. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml)
  • Table 95. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million)
  • Table 96. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2020-2025) & (M ml)
  • Table 100. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2026-2031) & (M ml)
  • Table 101. United Biomedical Company Information
  • Table 102. United Biomedical Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2020-2025)
  • Table 103. United Biomedical Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 104. United Biomedical Recent Developments
  • Table 105. CAHIC Company Information
  • Table 106. CAHIC Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2020-2025)
  • Table 107. CAHIC Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 108. Xinjiang Tecon Company Information
  • Table 109. Xinjiang Tecon Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2020-2025)
  • Table 110. Xinjiang Tecon Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. ISA Pharmaceuticals Company Information
  • Table 112. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 113. Lytix Biopharma Company Information
  • Table 114. Lytix Biopharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. Merck Company Information
  • Table 116. Merck Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 117. OncoTherapy Science Company Information
  • Table 118. OncoTherapy Science Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Circio Company Information
  • Table 120. Circio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Circio Recent Developments
  • Table 122. Stemline Therapeutics Company Information
  • Table 123. Stemline Therapeutics Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Treos Bio Company Information
  • Table 125. Treos Bio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Raw Materials Key Suppliers Lists
  • Table 127. Synthetic Peptide Vaccine Market Trends
  • Table 128. Synthetic Peptide Vaccine Market Drivers
  • Table 129. Synthetic Peptide Vaccine Market Challenges
  • Table 130. Synthetic Peptide Vaccine Market Restraints
  • Table 131. Research Programs/Design for This Report
  • Table 132. Key Data Information from Secondary Sources
  • Table 133. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Synthetic Peptide Vaccine Product Picture
  • Figure 2. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Synthetic Peptide Vaccine Market Share by Type: 2024 & 2031
  • Figure 4. FMD Type O Product Picture
  • Figure 5. FMD Type O+A Product Picture
  • Figure 6. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 7. Global Synthetic Peptide Vaccine Market Share by Application: 2024 & 2031
  • Figure 8. Synthetic Peptide Vaccine Report Years Considered
  • Figure 9. Global Synthetic Peptide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
  • Figure 10. Global Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 11. Global Synthetic Peptide Vaccine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 12. Global Synthetic Peptide Vaccine Revenue Market Share by Region in Percentage: 2024 Versus 2031
  • Figure 13. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2031)
  • Figure 14. Global Synthetic Peptide Vaccine Sales (2020-2031) & (M ml)
  • Figure 15. Global Synthetic Peptide Vaccine Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (M ml)
  • Figure 16. Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2031)
  • Figure 17. US & Canada Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml)
  • Figure 18. US & Canada Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million)
  • Figure 19. Europe Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml)
  • Figure 20. Europe Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million)
  • Figure 21. China Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml)
  • Figure 22. China Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million)
  • Figure 23. Asia (excluding China) Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml)
  • Figure 24. Asia (excluding China) Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million)
  • Figure 25. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml)
  • Figure 26. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million)
  • Figure 27. Global Synthetic Peptide Vaccine Sales Share by Manufacturers (2024)
  • Figure 28. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2024)
  • Figure 29. Global Synthetic Peptide Vaccine Sales Market Share by Type (2020-2031)
  • Figure 30. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2020-2031)
  • Figure 31. Global Synthetic Peptide Vaccine Sales Market Share by Application (2020-2031)
  • Figure 32. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2020-2031)
  • Figure 33. US & Canada Synthetic Peptide Vaccine Sales Market Share by Type 2024
  • Figure 34. US & Canada Synthetic Peptide Vaccine Revenue Market Share by Type 2024
  • Figure 35. US & Canada Synthetic Peptide Vaccine Sales Market Share by Application 2024
  • Figure 36. US & Canada Synthetic Peptide Vaccine Revenue Market Share by Application 2024
  • Figure 37. US & Canada Synthetic Peptide Vaccine Revenue Share by Country 2024
  • Figure 38. US & Canada Synthetic Peptide Vaccine Sales Share by Country 2024
  • Figure 39. US Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 40. Canada Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 41. Mexico Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 42. Europe Synthetic Peptide Vaccine Sales Market Share by Type 2024
  • Figure 43. Europe Synthetic Peptide Vaccine Revenue Market Share by Type 2024
  • Figure 44. Europe Synthetic Peptide Vaccine Sales Market Share by Application 2024
  • Figure 45. Europe Synthetic Peptide Vaccine Revenue Market Share by Application 2024
  • Figure 46. Europe Synthetic Peptide Vaccine Revenue Share by Country 2024
  • Figure 47. Europe Synthetic Peptide Vaccine Sales Share by Country 2024
  • Figure 48. Germany Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 49. France Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 50. U.K. Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 51. Italy Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 52. Russia Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 53. China Synthetic Peptide Vaccine Sales Market Share by Type 2024
  • Figure 54. China Synthetic Peptide Vaccine Revenue Market Share by Type 2024
  • Figure 55. China Synthetic Peptide Vaccine Sales Market Share by Application 2024
  • Figure 56. China Synthetic Peptide Vaccine Revenue Market Share by Application 2024
  • Figure 57. Asia Synthetic Peptide Vaccine Sales Market Share by Type 2024
  • Figure 58. Asia Synthetic Peptide Vaccine Revenue Market Share by Type 2024
  • Figure 59. Asia Synthetic Peptide Vaccine Sales Market Share by Application 2024
  • Figure 60. Asia Synthetic Peptide Vaccine Revenue Market Share by Application 2024
  • Figure 61. Asia Synthetic Peptide Vaccine Revenue Share by Region 2024
  • Figure 62. Asia Synthetic Peptide Vaccine Sales Share by Region 2024
  • Figure 63. Japan Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 64. South Korea Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 65. China Taiwan Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 66. Southeast Asia Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 67. India Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 68. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Market Share by Type 2024
  • Figure 69. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Market Share by Type 2024
  • Figure 70. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Market Share by Application 2024
  • Figure 71. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Market Share by Application 2024
  • Figure 72. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Share by Country 2024
  • Figure 73. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Share by Country 2024
  • Figure 74. Latin America Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 75. Middle East Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 76. Africa Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million)
  • Figure 77. UBI Group Of Companies
  • Figure 78. UBI Group Has Three Development Platforms
  • Figure 79. Synthetic Peptide Vaccine Value Chain
  • Figure 80. Bottom-up and Top-down Approaches for This Report
  • Figure 81. Data Triangulation
  • Figure 82. Key Executives Interviewed